Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
HLS THERAPEUTCS (T.HLS) had Consolidated Net Income/Loss of -2.31M for the most recently reported fiscal quarter, ending 2020-09-30.
| Income Statement Financials | |
-- |
|
-2.31M |
|
-- |
|
-- |
|
-- |
|
-2.34M |
|
-- |
|
-1.97M |
|
-1.97M |
|
-2.31M |
|
-2.31M |
|
|
Consolidated Net Income/Loss |
-2.31M |
-2.31M |
|
-2.34M |
|
5.97M |
|
31.74M |
|
31.74M |
|
-0.07 |
|
-0.07 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
407.80M |
|
-- |
|
-- |
|
-- |
|
182.78M |
|
225.02M |
|
-114.43M |
|
225.02M |
|
31.74M |
|
| Cash Flow Statement Financials | |
4.66M |
|
-55.78M |
|
17.61M |
|
62.74M |
|
27.84M |
|
-34.90M |
|
0.15M |
|
-4.68M |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.32 |
|
-- |
|
-- |
|
0.38 |
|
0.70 |
|
93.72% |
|
-13.35% |
|
-13.35% |
|
-- |
|
-11.28% |
|
-13.20% |
|
-9.01M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
0.07 |
|
1.05 |
|
85.93 |
|
-1.03% |
|
2.02% |
|
-0.57% |
|
-0.64% |
|
7.09 |
|
-0.28 |
|
0.15 |
|